Oncternal Therapeutics Inc. (ONCT) Tops Q2 EPS by 1c

Oncternal Therapeutics Inc. (NASDAQ: ONCT) reported Q2 EPS of ($0.15), $0.01 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $106 thousand versus the consensus estimate of $170.83 thousand.

For earnings history and earnings-related data on Oncternal Therapeutics Inc. (ONCT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79